Analyst firms · H.C. Wainwright · BNTX

H.C. Wainwright BNTX price target and rating history

BioNTech SE (BNTX) · Health Care

H.C. Wainwright rates BioNTech SE (BNTX) Buy with a $145 price target, as of its latest action on Jun 5, 2025. It has published 5 rating actions on BNTX since August 2021, including 1 upgrade and 0 downgrades. Across 5 firms with a BNTX price target in the last 12 months, the median target is $113.

Current rating
Buy
Price target
$145
Median target, all firms
$113
Actions on BNTX
5

H.C. Wainwright price target on BNTX

$366$256$14520222023202420252026
H.C. Wainwright price target on BNTX, each point a stated target, August 2021 to June 2025.

Every H.C. Wainwright rating on BNTX

How other firms rate BNTX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchHoldOct 8, 2026
BMO Capital MarketsMarket Perform$105Sep 8, 2026
UBSBuy$135May 27, 2026
BernsteinMkt Perform$96May 22, 2026
Leerink PartnersMarket Perform$113Feb 2, 2026
Goldman SachsBuy$142Jan 16, 2026

Questions about H.C. Wainwright and BNTX

What is H.C. Wainwright's price target for BNTX?
H.C. Wainwright's latest stated price target for BioNTech SE (BNTX) is $145, from its action on Jun 5, 2025.
What is H.C. Wainwright's rating on BNTX?
H.C. Wainwright rates BNTX Buy, a bullish rating, as of Jun 5, 2025.
When did H.C. Wainwright last change its view on BNTX?
On Jun 5, 2025, H.C. Wainwright raises its price target to $145 from $134, keeps Buy.
How does H.C. Wainwright's BNTX target compare with other analysts?
Across 5 firms with a BNTX price target in the last 12 months, the median target is $113.

More BNTX rating histories

All H.C. Wainwright ratingsBNTX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.